A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT04944784 · TERMINATED

Trial details

NCT number: NCT04944784
Sponsor: Cytokinetics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2021-08-16
Primary completion: 2023-07-18
Enrollment: 489

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.